BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26290198)

  • 1. Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery.
    Lip Kwok PC
    Curr Pharm Des; 2015; 21(27):3945-54. PubMed ID: 26290198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatics of pharmaceutical inhalation aerosols.
    Kwok PC; Chan HK
    J Pharm Pharmacol; 2009 Dec; 61(12):1587-99. PubMed ID: 19958580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.
    Lin YW; Wong J; Qu L; Chan HK; Zhou QT
    Curr Pharm Des; 2015; 21(27):3902-16. PubMed ID: 26290193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of factors affecting electrostatic charging of pharmaceuticals and adhesive mixtures for inhalation.
    Kaialy W
    Int J Pharm; 2016 Apr; 503(1-2):262-76. PubMed ID: 26836710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical aerosol electrostatics: a field with much potential for development.
    Lip Kwok PC
    Ther Deliv; 2015 Feb; 6(2):105-7. PubMed ID: 25690079
    [No Abstract]   [Full Text] [Related]  

  • 7. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatic charge characteristics of aerosols produced from metered dose inhalers.
    Kwok PC; Glover W; Chan HK
    J Pharm Sci; 2005 Dec; 94(12):2789-99. PubMed ID: 16258995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PulmoSphereâ„¢ platform for pulmonary drug delivery.
    Weers J; Tarara T
    Ther Deliv; 2014 Mar; 5(3):277-95. PubMed ID: 24592954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrostatics in pharmaceutical aerosols for inhalation.
    Wong J; Chan HK; Kwok PC
    Ther Deliv; 2013 Aug; 4(8):981-1002. PubMed ID: 23919475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.
    Cheng YS
    AAPS PharmSciTech; 2014 Jun; 15(3):630-40. PubMed ID: 24563174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Electrostatic Behavior of Dry Powder-Inhaled Model Formulations.
    Jetzer MW; Morrical BD
    J Pharm Sci; 2019 Sep; 108(9):2949-2963. PubMed ID: 31004652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Active Pharmaceutical Ingredients on Aerosol Electrostatic Charges from Pressurized Metered Dose Inhalers.
    Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
    Pharm Res; 2015 Sep; 32(9):2928-36. PubMed ID: 25788449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Spacers on the Bipolar Electrostatic Charge Properties of Metered Dose Inhaler Aerosols-A Case Study With Tilade
    Leung SSY; Chiow ACM; Kwok PCL; Ukkonen A; Chan HK
    J Pharm Sci; 2017 Jun; 106(6):1553-1559. PubMed ID: 28238902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.